発表論文

発表論文

総説(脈管研究関連)  (3-2023現在)

  1. Eguchi R, Kawabe JI and Wakabayashi I. VEGF-Independent Angiogenic Factors: Beyond VEGF/VEGFR2 Signaling. J Vasc Res. 2022;59:78-89.
  2. Kawabe J. EphA7+ multipotent pericytes and their roles in multicellular organisms. Stem Cell Biology and Regenerative Medicine. 2021;68:189-201.
  3. Kawabe J and Hasebe N. Role of the vasa vasorum and vascular resident stem cells in atherosclerosis. BioMed research international. 2014;2014:701571.
  4. Yuhki K, Kojima F, Kashiwagi H, Kawabe J, Fujino T, Narumiya S and Ushikubi F. Roles of prostanoids in the pathogenesis of cardiovascular diseases: Novel insights from knockout mouse studies. Pharmacology & therapeutics. 2011;129:195-205.
  5. Yuhki K, Kashiwagi H, Kojima F, Kawabe J and Ushikubi F. Roles of prostanoids in the pathogenesis of cardiovascular diseases. International angiology : a journal of the International Union of Angiology. 2010;29:19-27.
  6. Kawabe J, Ushikubi F and Hasebe N. Prostacyclin in vascular diseases. - Recent insights and future perspectives. Circulation journal : official journal of the Japanese Circulation Society. 2010;74:836-43.
  7. Yuhki K, Kawabe J and Ushikubi F. Fat, keeping the heart healthy? Nature medicine. 2005;11:1048-9.

原書論文(脈管研究関連)  (3-2023現在)

  1. Sano T, Nakajima T, Senda KA, Nakano S, Yamato M, Ikeda Y, Zeng H, Kawabe JI and Matsunaga YT. Image-based crosstalk analysis of cell-cell interactions during sprouting angiogenesis using blood-vessel-on-a-chip. Stem Cell Res Ther. 2022;13:532.
  2. Matsuo R, Kishibe M, Horiuchi K, Kano K, Tatsukawa T, Hayasaka T, Kabara M, Iinuma S, Eguchi R, Igawa S, Hasebe N, Ishida-Yamamoto A and Kawabe JI. Ninjurin1 Deletion in NG2-Positive Pericytes Prevents Microvessel Maturation and Delays Wound Healing. JID Innov. 2022;2:100141.
  3. Kanno T, Nakagawa N, Aonuma T, Kawabe JI, Yuhki KI, Takehara N, Hasebe N and Ushikubi F. Prostaglandin E(2) mediates the late phase of ischemic preconditioning in the heart via its receptor subtype EP(4). Heart and vessels. 2022.
  4. Horiuchi K, Kano K, Minoshima A, Hayasaka T, Yamauchi A, Tatsukawa T, Matsuo R, Yoshida Y, Tomita Y, Kabara M, Nakagawa N, Takehara N, Hasebe N and Kawabe JI. Pericyte-specific deletion of ninjurin-1 induces fragile vasa vasorum formation and enhances intimal hyperplasia of injured vasculature. American journal of physiology Heart and circulatory physiology. 2021;320:H2438-H2447.
  5. Yoshida Y, Kabara M, Kano K, Horiuchi K, Hayasaka T, Tomita Y, Takehara N, Minoshima A, Aonuma T, Maruyama K, Nakagawa N, Azuma N, Hasebe N and Kawabe JI. Capillary-resident EphA7(+) pericytes are multipotent cells with anti-ischemic effects through capillary formation. Stem cells translational medicine. 2020;9:120-130.
  6. Kano K, Horiuchi K, Yoshida Y, Hayasaka T, Kabara M, Tomita Y, Tatsukawa T, Matsuo R, Sawada J, Nakagawa N, Takehara N, Hasebe N and Kawabe JI. EphA7(+) perivascular cells as myogenic and angiogenic precursors improving skeletal muscle regeneration in a muscular dystrophic mouse model. Stem Cell Res. 2020;47:101914.
  7. Tomita Y, Horiuchi K, Kano K, Tatsukawa T, Matsuo R, Hayasaka T, Yoshida Y, Kabara M, Yasuda S, Nakajima K, Nakagawa N, Takehara N, Okizaki A, Hasebe N and Kawabe JI. Ninjurin 1 mediates peripheral nerve regeneration through Schwann cell maturation of NG2-positive cells. Biochemical and biophysical research communications. 2019;519:462-468.
  8. Minoshima A, Kabara M, Matsuki M, Yoshida Y, Kano K, Tomita Y, Hayasaka T, Horiuchi K, Saito Y, Aonuma T, Nishimura M, Maruyama K, Nakagawa N, Sawada J, Takehara N, Hasebe N and Kawabe JI. Pericyte-Specific Ninjurin1 Deletion Attenuates Vessel Maturation and Blood Flow Recovery in Hind Limb Ischemia. Arteriosclerosis, thrombosis, and vascular biology. 2018;38:2358-2370.
  9. Lee E, Takahashi H, Pauty J, Kobayashi M, Kato K, Kabara M, Kawabe JI and Matsunaga YT. A 3D in vitro pericyte-supported microvessel model: visualisation and quantitative characterisation of multistep angiogenesis. J Mater Chem B. 2018;6:1085-1094.
  10. Aonuma T, Takehara N, Maruyama K, Kabara M, Matsuki M, Yamauchi A, Kawabe J and Hasebe N. Apoptosis-Resistant Cardiac Progenitor Cells Modified With Apurinic/Apyrimidinic Endonuclease/Redox Factor 1 Gene Overexpression Regulate Cardiac Repair After Myocardial Infarction. Stem cells translational medicine. 2016;5:1067-78.
  11. Ota H, Takehara N, Aonuma T, Kabara M, Matsuki M, Yamauchi A, Takeuchi T, Kawabe J and Hasebe N. Association between Microalbuminuria Predicting In-Stent Restenosis after Myocardial Infarction and Cellular Senescence of Endothelial Progenitor Cells. PloS one. 2015;10:e0123733.
  12. Minami Y, Sasaki T, Bochimoto H, Kawabe J, Endo S, Hira Y, Watanabe T, Okumura S, Hasebe N and Ohsaki Y. Prostaglandin I2 analog suppresses lung metastasis by recruiting pericytes in tumor angiogenesis. International journal of oncology. 2015;46:548-54.
  13. Matsuki M, Kabara M, Saito Y, Shimamura K, Minoshima A, Nishimura M, Aonuma T, Takehara N, Hasebe N and Kawabe JI. Ninjurin1 Is a Novel Factor to Regulate Angiogenesis Through the Function of Pericytes. Circulation journal : official journal of the Japanese Circulation Society. 2015.
  14. Sakamoto N, Sato N, Goto M, Kobayashi M, Takehara N, Takeuchi T, Talib AK, Sugiyama E, Minoshima A, Tanabe Y, Akasaka K, Kawabe J, Kawamura Y, Doi A and Hasebe N. Three cases of corticosteroid therapy triggering ventricular fibrillation in J-wave syndromes. Heart and vessels. 2014;29:867-72.
  15. Noro T, Takehara N, Sumitomo K, Takeuchi T, Ishii Y, Kato J, Kawabe J and Hasebe N. Initial reduction of oxidative stress by angiotensin receptor blocker contributes long term outcomes after percutaneous coronary intervention. American journal of cardiovascular disease. 2014;4:159-67.
  16. Kabara M, Kawabe J, Matsuki M, Hira Y, Minoshima A, Shimamura K, Yamauchi A, Aonuma T, Nishimura M, Saito Y, Takehara N and Hasebe N. Immortalized multipotent pericytes derived from the vasa vasorum in the injured vasculature. A cellular tool for studies of vascular remodeling and regeneration. Laboratory investigation; a journal of technical methods and pathology. 2014;94:1340-54.
  17. Izawa K, Okada M, Sumitomo K, Nakagawa N, Aizawa Y, Kawabe J, Kikuchi K and Hasebe N. Impaired glutathione redox system paradoxically suppresses angiotensin II-induced vascular remodeling. PloS one. 2014;9:e108115.
  18. Asanome A, Kawabe J, Matsuki M, Kabara M, Hira Y, Bochimoto H, Yamauchi A, Aonuma T, Takehara N, Watanabe T and Hasebe N. Nerve growth factor stimulates regeneration of perivascular nerve, and induces the maturation of microvessels around the injured artery. Biochemical and biophysical research communications. 2014;443:150-5.
  19. Yamauchi A, Kawabe J, Kabara M, Matsuki M, Asanome A, Aonuma T, Ohta H, Takehara N, Kitagawa T and Hasebe N. Apurinic/apyrimidinic endonucelase 1 maintains adhesion of endothelial progenitor cells and reduces neointima formation. American journal of physiology Heart and circulatory physiology. 2013;305:H1158-67.
  20. Aburakawa Y, Kawabe J, Okada M, Yamauchi A, Asanome A, Kabara M, Matsuki M, Takehara N, Nakagawa N, Okumura S, Minami Y, Mizukami Y, Yuhki K, Ushikubi F and Hasebe N. Prostacyclin stimulated integrin-dependent angiogenic effects of endothelial progenitor cells and mediated potent circulation recovery in ischemic hind limb model. Circulation journal : official journal of the Japanese Circulation Society. 2013;77:1053-62.
  21. Nakagawa N, Yuhki K, Kawabe J, Fujino T, Takahata O, Kabara M, Abe K, Kojima F, Kashiwagi H, Hasebe N, Kikuchi K, Sugimoto Y, Narumiya S and Ushikubi F. The intrinsic prostaglandin E2-EP4 system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice. Kidney international. 2012;82:158-71.
  22. Nakagawa N, Ota H, Tanabe Y, Kabara M, Matsuki M, Chinda J, Sakamoto N, Fujino T, Takehara N, Takeuchi T, Kawabe J, Sato N, Kawamura Y, Fukuhara T, Ikuta K, Kikuchi K and Hasebe N. A case of idiopathic systemic capillary leak syndrome with high serum levels of G-CSF on exacerbation. Internal medicine. 2011;50:597-600.
  23. Nakagawa N, Maruyama H, Ishihara T, Seino U, Kawabe J, Takahashi F, Kobayashi M, Yamauchi A, Sasaki Y, Sakamoto N, Ota H, Tanabe Y, Takeuchi T, Takenaka T, Kikuchi K and Hasebe N. Clinical and genetic investigation of a Japanese family with cardiac fabry disease. Identification of a novel alpha-galactosidase A missense mutation (G195V). International heart journal. 2011;52:308-11.
  24. Kawabe J, Yuhki K, Okada M, Kanno T, Yamauchi A, Tashiro N, Sasaki T, Okumura S, Nakagawa N, Aburakawa Y, Takehara N, Fujino T, Hasebe N, Narumiya S and Ushikubi F. Prostaglandin I2 promotes recruitment of endothelial progenitor cells and limits vascular remodeling. Arteriosclerosis, thrombosis, and vascular biology. 2010;30:464-70.
  25. Tashiro N, Sato N, Talib AK, Talib AK, Saito E, Okura M, Yamaki M, Nakagawa N, Sakamoto N, Ota H, Tanabe Y, Takeuchi T, Akasaka K, Kawabe J, Kawamura Y and Hasebe N. Brugada syndrome case: difficult differentiation between a concealed form and tricyclic antidepressant-induced Brugada sign. Internal medicine. 2009;48:1535-9.
  26. Sasaki T, Tanno S, Shibukawa K, Osanai S, Kawabe J and Ohsaki Y. Administration of VEGF receptor tyrosine kinase inhibitor increases VEGF production causing angiogenesis in human small-cell lung cancer xenografts. International journal of oncology. 2008;33:525-32.
  27. Okumura S, Vatner DE, Kurotani R, Bai Y, Gao S, Yuan Z, Iwatsubo K, Ulucan C, Kawabe J, Ghosh K, Vatner SF and Ishikawa Y. Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress. Circulation. 2007;116:1776-83.
  28. Kawabe J, Okumura S, Nathanson MA, Hasebe N and Ishikawa Y. Caveolin regulates microtubule polymerization in the vascular smooth muscle cells. Biochemical and biophysical research communications. 2006;342:164-9.
  29. Takehara N, Makita N, Kawabe J, Sato N, Kawamura Y, Kitabatake A and Kikuchi K. A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill. J Intern Med. 2004;255:137-42.
  30. Oshikawa J, Otsu K, Toya Y, Tsunematsu T, Hankins R, Kawabe J, Minamisawa S, Umemura S, Hagiwara Y and Ishikawa Y. Insulin resistance in skeletal muscles of caveolin-3-null mice. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:12670-5.
  31. Okada M, Hasebe N, Aizawa Y, Izawa K, Kawabe J and Kikuchi K. Thermal treatment attenuates neointimal thickening with enhanced expression of heat-shock protein 72 and suppression of oxidative stress. Circulation. 2004;109:1763-8.
  32. Kawabe J, Okumura S, Lee MC, Sadoshima J and Ishikawa Y. Translocation of caveolin regulates stretch-induced ERK activity in vascular smooth muscle cells. American journal of physiology Heart and circulatory physiology. 2004;286:H1845-52.
  33. Oshikawa J, Toya Y, Fujita T, Egawa M, Kawabe J, Umemura S and Ishikawa Y. Nicotinic acetylcholine receptor alpha 7 regulates cAMP signal within lipid rafts. Am J Physiol Cell Physiol. 2003;285:C567-74.
  34. Okumura S, Takagi G, Kawabe J, Yang G, Lee MC, Hong C, Liu J, Vatner DE, Sadoshima J, Vatner SF and Ishikawa Y. Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proceedings of the National Academy of Sciences of the United States of America. 2003;100:9986-90.
  35. Okumura S, Kawabe J, Yatani A, Takagi G, Lee MC, Hong C, Liu J, Takagi I, Sadoshima J, Vatner DE, Vatner SF and Ishikawa Y. Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation. Circulation research. 2003;93:364-71.
  36. Iwamoto T, Okumura S, Iwatsubo K, Kawabe J, Ohtsu K, Sakai I, Hashimoto Y, Izumitani A, Sango K, Ajiki K, Toya Y, Umemura S, Goshima Y, Arai N, Vatner SF and Ishikawa Y. Motor dysfunction in type 5 adenylyl cyclase-null mice. The Journal of biological chemistry. 2003;278:16936-40.
  37. Fujino T, Hasebe N, Kawabe J, Fujita M, Fukuzawa J, Tobise K and Kikuchi K. Effect of beta-adrenoceptor antagonist and angiotensin-converting enzyme inhibitor on hypertension-associated changes in adenylyl cyclase type V messenger RNA expression in spontaneously hypertensive rats. Journal of cardiovascular pharmacology. 2003;41:720-5.
  38. Shiokoshi T, Ohsaki Y, Kawabe J, Fujino T and Kikuchi K. Downregulation of nitric oxide accumulation by cyclooxygenase-2 induction and thromboxane A2 production in interleukin-1beta-stimulated rat aortic smooth muscle cells. Journal of hypertension. 2002;20:455-61.
  39. Matsusaka T, Hasebe N, Jin YT, Kawabe J and Kikuchi K. Magnesium reduces myocardial infarct size via enhancement of adenosine mechanism in rabbits. Cardiovascular research. 2002;54:568-75.
  40. Kawabe JI, Grant BS, Yamamoto M, Schwencke C, Okumura S and Ishikawa Y. Changes in caveolin subtype protein expression in aging rat organs. Molecular and cellular endocrinology. 2001;176:91-5.
  41. Aizawa Y, Kawabe J, Hasebe N, Takehara N and Kikuchi K. Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia. Circulation. 2001;104:455-60.
  42. Takehara N, Kawabe J, Aizawa Y, Hasebe N and Kikuchi K. High glucose attenuates insulin-induced mitogen-activated protein kinase phosphatase-1 (MKP-1) expression in vascular smooth muscle cells. Biochimica et biophysica acta. 2000;1497:244-52.